Market Cap 6.10M
Revenue (ttm) 0.00
Net Income (ttm) 42.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 612,679
Avg Vol 3,792,305
Day's Range N/A - N/A
Shares Out 10.53M
Stochastic %K 17%
Beta 0.27
Analysts Strong Sell
Price Target $359.71

Latest News on AEON

AEON Biopharma Announces CEO Transition

Mar 27, 2025, 4:05 PM EDT - 6 days ago

AEON Biopharma Announces CEO Transition


AEON Biopharma, Inc. Announces Reverse Stock Split

Feb 24, 2025, 2:00 PM EST - 5 weeks ago

AEON Biopharma, Inc. Announces Reverse Stock Split


AEON Biopharma Reports First Quarter 2024 Financial Results

May 14, 2024, 4:05 PM EDT - 11 months ago

AEON Biopharma Reports First Quarter 2024 Financial Results


AEON Biopharma Provides Update on Development Pipeline

May 9, 2024, 8:00 AM EDT - 11 months ago

AEON Biopharma Provides Update on Development Pipeline


AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 4:15 PM EDT - 1 year ago

AEON Biopharma Announces Redemption of Public Warrants


AEON Biopharma Reports Third Quarter 2023 Financial Results

Nov 13, 2023, 8:15 AM EST - 1 year ago

AEON Biopharma Reports Third Quarter 2023 Financial Results